Table 5 CEA with a health outcome: cost per HIV infection averted
From: Cost-effectiveness analyses of training: a manager’s guide
Pre-training | Post-training | |
|---|---|---|
Program cost | ||
Remuneration | ||
Clinical staff, including counselors | $65,000 | $72,000 |
Supervisory staff | $15,000 | $12,000 |
Total remuneration | $80,000 | $84,000 |
Supplies, including HIV test kits and ARV drugs | $15,000 | $18,000 |
Capital (annuitized) | ||
Vehicle | $3,000 | $3,000 |
Equipment | $500 | $500 |
Building | $1,500 | $1,500 |
Training | $0 | $5,000 |
Total Capital | $5,000 | $10,000 |
Total program cost | $100,000 | $112,000 |
Estimate of effectiveness | ||
Number of mother infant pairs that PMTCT | 1000 | 1200 |
Estimated vertical HIV transmission before and at birth* | ||
Base case | 25% | 25% |
Lower bound | 19% | 19% |
Upper bound | 30% | 30% |
Effectiveness of regimen for mothers and infant | 63% | 63% |
Estimated HIV infections averted | ||
Base case | (1000*.25*.63) =158 | (1000*.25*.63) =189 |
Lower bound | 120 | 144 |
Upper bound | 189 | 227 |
Cost-effectiveness analysis | ||
Incremental cost | ($112,000-$100,000) = $12,000 | |
Incremental HIV infection averted | ||
Base case | (189–158) = 31 | |
Lower bound | (144–120) = 24 | |
Upper bound | (227–189) = 38 | |
Incremental cost-effectiveness ratio (ICER) | ||
Base case | ($12,000/31)=$283 | |
Lower bound | $215 | |
Upper bound | $340 | |